The treatment and outcomes of early-stage epithelial ovarian cancer: Have we made any progress?

British Journal of Cancer

Volumn 98, Issue 7, 2008, Pages 1191-1196

  Chan, J K ^a   Fuh, K ^b   Shin, J Y ^a   Cheung, M K ^a   Powell, C B ^a   Chen, L M ^a   Kapp, D S ^b   Osann, K ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Early stage; Epithelial ovarian cancer; Progress

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; TREATMENT OUTCOME; WOMEN'S HEALTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 41649120153     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604299     Document Type: Article

References (35)

1. Ahmed FY, Wiltshaw E, A'Hern RP, Nicol B, Shepherd J, Blake P, Fisher C, Gore ME (1996) Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Oncol 14: 2968-2975
2. Averette HE, Janicek MF, Menck HR (1995) The National Cancer Data Base report on ovarian cancer. American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 76: 1096-1103
3. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR (2003) Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189: 1120-1127
4. Bertelsen K, Holund B, Andersen JE, Nielsen K, Stroyer I, Ladehoff P (1993) Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int J Gynecol Cancer 3: 211-218
5. Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360: 1131-1135
6. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K (2006) Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 108: 521-528
7. Chan JK, Kapp DS, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Leiserowitz GS, Cress RD, O'Malley C (2007a) Influence of the gynecologic oncologist on the survival of ovarian cancer patients. Obstet Gynecol 109(6): 1342-1350
8. Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K (2007b) Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 109: 12-19
9. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC (2008) Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group Study. Cancer (in press)
10. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP, Ngan HY, Pecorelli S (2003) Carcinoma of the corpus uteri. Int J Gynaecol Obstet 83(Suppl 1): 79-118
11. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL (2003) Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol 21: 1530-1535
12. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K (1990) Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 75: 263-273
13. Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, Kimmig R, Rehbock J, Holzel D (2002) Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer 38: 2435-2445
14. Finn CB, Luesley DM, Buxton EJ, Blackledge GR, Kelly K, Dunn JA, Wilson S (1992) Is stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. Br J Obstet Gynaecol 99: 54-58
15. Heintz AP, Odicino F, Maisonneuve P, Benedet JL, Creasman WT, Ngan HY, Pecorelli S, Beller U (2006) Carcinoma of the ovary. Int J Gynaecol Obstet 95(S1): S161-S192
16. Helewa ME, Krepart GV, Lotocki R (1986) Staging laparotomy in early epithelial ovarian carcinoma. Am J Obstet Gynecol 154: 282-286
17. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3-10
18. Hoskins PJ, Swenerton KD, Manji M, Wong F, O'Reilly SE, McMurtrie EJ, Le N, Acker B, Le Richer J (1994) 'Moderate-risk' ovarian cancer (stage I, grade 2; stage II, grade 1 or 2) treated with cisplatin chemotherapy (single agent or combination) and pelvi-abdominal irradiation. Int J Gynecol Cancer 4: 272-278
19. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130
20. Kosary CL (1994) FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10: 31-46
21. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin Oncol 23: 40-47
22. Nguyen HN, Averette HE, Hoskins W, Sevin BU, Penalver M, Steren A (1993) National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system. Cancer 72: 3007-3011
23. Partridge EE, Phillips JL, Menck HR (1996) The National Cancer Data Base report on ovarian cancer treatment in United States hospitals. Cancer 78: 2236-2246
24. Pectasides D, Fountzilas G, Aravantinos G, Bamias A, Kalofonos HP, Skarlos D, Briasoulis E, Konstantara A, Economopoulos T, Dimopoulos MA (2007) Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience. Int J Gynecol Cancer 17: 1003-1010
25. Pettersson F (1988) International Federation of Gynecology and Obstetrics annual report on the results of treatment in gynecologic cancer, Vol. 20, p 110. Stockholm, Sweden: Panorama Press AB
26. Schildkraut JM, Halabi S, Bastos E, Marchbanks PA, McDonald JA, Berchuck A (2000) Prognostic factors in early-onset epithelial ovarian cancer: a population-based study. Obstet Gynecol 95: 119-127
27. Sevelda P, Vavra N, Schemper M, Salzer H (1990) Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer 65: 2349-2352
28. Sjovall K, Nilsson B, Einhorn N (1994) Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinoma. Int J Gynecol Cancer 4: 333-336
29. Soper JT, Johnson P, Johnson V, Berchuck A, Clarke-Pearson DL (1992) Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol 80: 949-953
30. Surveillance, Epidemiology and End Results (SEER) Program (2005) SEER*Stat Database: Incidence - SEER 12 Regs Public-Use, November 2004 Sub (1988-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Available at http://seer.cancer.gov/. Released April 2005
31. Trope C, Kaern J, Hogberg T, Abeler V, Hagen B, Kristensen G, Onsrud M, Pettersen E, Rosenberg P, Sandvei R, Sundfor K, Vergote I (2000) Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann Oncol 11: 281-288
32. Vergote IB, Kaern J, Abeler VM, Pettersen EO, De Vos LN, Trope CG (1993) Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol 169: 40-52
33. Yancik R (1993) Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer 71: 517-523
34. Young RC, Decker DG, Wharton JT, Piver MS, Sindelar WF, Edwards BK, Smith JP (1983) Staging laparotomy in early ovarian cancer. JAMA 250: 3072-3076
35. Young RC, Walton LA, Ellenberg SS, Homesley HD, Wilbanks GD, Decker DG, Miller A, Park R, Major Jr F (1990) Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med 322: 1021-1027